Cargando…

Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study

OBJECTIVE: The protection from SARS-CoV-2 infection induced by SARS-CoV-2 anti-S1 and anti-S2 IgG antibody positivity resulting from natural infection was evaluated. METHODS: The frequency of SARS-CoV-2 infection (as determined by virus RNA detection) was evaluated in a group of 1,460 seropositive a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovida, Francesca, Cassaniti, Irene, Percivalle, Elena, Sarasini, Antonella, Paolucci, Stefania, Klersy, Catherine, Cutti, Sara, Novelli, Viola, Marena, Carlo, Luzzaro, Francesco, De Vito, Giovanni, Schiavo, Roberta, Lo Cascio, Giuliana, Lilleri, Daniele, Baldanti, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260553/
https://www.ncbi.nlm.nih.gov/pubmed/34242763
http://dx.doi.org/10.1016/j.ijid.2021.07.003
_version_ 1783718831058845696
author Rovida, Francesca
Cassaniti, Irene
Percivalle, Elena
Sarasini, Antonella
Paolucci, Stefania
Klersy, Catherine
Cutti, Sara
Novelli, Viola
Marena, Carlo
Luzzaro, Francesco
De Vito, Giovanni
Schiavo, Roberta
Lo Cascio, Giuliana
Lilleri, Daniele
Baldanti, Fausto
author_facet Rovida, Francesca
Cassaniti, Irene
Percivalle, Elena
Sarasini, Antonella
Paolucci, Stefania
Klersy, Catherine
Cutti, Sara
Novelli, Viola
Marena, Carlo
Luzzaro, Francesco
De Vito, Giovanni
Schiavo, Roberta
Lo Cascio, Giuliana
Lilleri, Daniele
Baldanti, Fausto
author_sort Rovida, Francesca
collection PubMed
description OBJECTIVE: The protection from SARS-CoV-2 infection induced by SARS-CoV-2 anti-S1 and anti-S2 IgG antibody positivity resulting from natural infection was evaluated. METHODS: The frequency of SARS-CoV-2 infection (as determined by virus RNA detection) was evaluated in a group of 1,460 seropositive and a control group of 8,150 seronegative healthcare workers in three Centres of Northern Italy in the period June-November 2020. Neutralizing serum titers were analyzed in seropositive subjects with or without secondary SARS-CoV-2 infection. RESULTS: During the 6-month survey, 1.78% seropositive subjects developed secondary SARS-CoV-2 infection while 6.63% seronegative controls developed primary infection (odds ratio: 0.26; 95% confidence interval: 0.17-0.38). Secondary infection was associated with low or absent serum neutralizing titer (p<0.01) and was mildly symptomatic in 45.8% cases vs 71.4% symptomatic primary infections (odds ratio: 0.34; 95% confidence interval: 0.16-0.78). CONCLUSIONS: Immunity from natural infection appears protective from secondary infection; therefore, vaccination of seronegative subjects might be prioritized.
format Online
Article
Text
id pubmed-8260553
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82605532021-07-07 Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study Rovida, Francesca Cassaniti, Irene Percivalle, Elena Sarasini, Antonella Paolucci, Stefania Klersy, Catherine Cutti, Sara Novelli, Viola Marena, Carlo Luzzaro, Francesco De Vito, Giovanni Schiavo, Roberta Lo Cascio, Giuliana Lilleri, Daniele Baldanti, Fausto Int J Infect Dis Article OBJECTIVE: The protection from SARS-CoV-2 infection induced by SARS-CoV-2 anti-S1 and anti-S2 IgG antibody positivity resulting from natural infection was evaluated. METHODS: The frequency of SARS-CoV-2 infection (as determined by virus RNA detection) was evaluated in a group of 1,460 seropositive and a control group of 8,150 seronegative healthcare workers in three Centres of Northern Italy in the period June-November 2020. Neutralizing serum titers were analyzed in seropositive subjects with or without secondary SARS-CoV-2 infection. RESULTS: During the 6-month survey, 1.78% seropositive subjects developed secondary SARS-CoV-2 infection while 6.63% seronegative controls developed primary infection (odds ratio: 0.26; 95% confidence interval: 0.17-0.38). Secondary infection was associated with low or absent serum neutralizing titer (p<0.01) and was mildly symptomatic in 45.8% cases vs 71.4% symptomatic primary infections (odds ratio: 0.34; 95% confidence interval: 0.16-0.78). CONCLUSIONS: Immunity from natural infection appears protective from secondary infection; therefore, vaccination of seronegative subjects might be prioritized. Elsevier 2021-08 /pmc/articles/PMC8260553/ /pubmed/34242763 http://dx.doi.org/10.1016/j.ijid.2021.07.003 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Rovida, Francesca
Cassaniti, Irene
Percivalle, Elena
Sarasini, Antonella
Paolucci, Stefania
Klersy, Catherine
Cutti, Sara
Novelli, Viola
Marena, Carlo
Luzzaro, Francesco
De Vito, Giovanni
Schiavo, Roberta
Lo Cascio, Giuliana
Lilleri, Daniele
Baldanti, Fausto
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
title Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
title_full Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
title_fullStr Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
title_full_unstemmed Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
title_short Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
title_sort incidence of sars-cov-2 infection in health care workers from northern italy based on antibody status: immune protection from secondary infection- a retrospective observational case-controlled study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260553/
https://www.ncbi.nlm.nih.gov/pubmed/34242763
http://dx.doi.org/10.1016/j.ijid.2021.07.003
work_keys_str_mv AT rovidafrancesca incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT cassanitiirene incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT percivalleelena incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT sarasiniantonella incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT paoluccistefania incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT klersycatherine incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT cuttisara incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT novelliviola incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT marenacarlo incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT luzzarofrancesco incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT devitogiovanni incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT schiavoroberta incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT locasciogiuliana incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT lilleridaniele incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy
AT baldantifausto incidenceofsarscov2infectioninhealthcareworkersfromnorthernitalybasedonantibodystatusimmuneprotectionfromsecondaryinfectionaretrospectiveobservationalcasecontrolledstudy